Next Medical sold to OMX Group

The parties

Founded in 2010, Next Medical has built a portfolio of high-end medical device brands. The company provides distribution, technical assistance, training and support to healthcare professionals. The company’s portfolio includes Acumed, specialised in plates and screws for orthopedics and traumatology, MicroAire, focused on hand surgery, plastic surgery and power-assisted liposuction systems and Austofix, leading player in intramedullary nailing for traumatology.

OMX Group was founded in 2023 and is backed by Entrepreneur Invest and ISAI as shareholders, and Kartesia and Arkea as financial partners. OMX Group is the largest specialty MedTech distribution group in France. The group currently operates in seven therapeutic areas: ophthalmology, ENT and maxillofacial surgery, medical imaging and radiotherapy, physiotherapy, medical aesthetics, homecare, and defibrillation. The group is involved in an active buy-and-build strategy through 14 acquisitions, bringing together market leading companies while preserving their brands, expertise and teams, and supporting their growth through shared resources and financial capabilities.

The outcome

The acquisition of Next Medical strengthens OMX’s international footprint and expands its platform into the Italian market. It adds Next Medical’s specialized expertise and portfolio of medical device brands to the group’s growing European network. OMX’s ambition is to act as a strategic partner for healthcare practitioners and manufacturers, with the ultimate goal of contributing to the efficiency of the healthcare ecosystem.

Founder  of Next Medical, Tommaso Cherubino, will become a significant shareholder of the group and continue to operate and develop Next Medical. The company will benefit from significant resources to accelerate the growth of the business both organically and through M&A, holding a coordinating role for OMX Group in the orthopaedic segment.

Clairfield role

Clairfield acted as exclusive advisor to Next Medical.